Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-01 9:47 pm Purchase |
2025-03-25 | 13G | Zenas BioPharma, Inc. ZBIO |
Novo Holdings A/S | 2,214,967 5.300% |
2,214,967 (New Position) |
Filing History |
| 2024-11-12 10:40 am Purchase |
2024-11-08 | 13G | Zenas BioPharma, Inc. ZBIO |
FMR CORP | 2,000,000 5.026% |
2,000,000 (New Position) |
Filing History |
| 2024-10-21 4:18 pm Purchase |
2024-09-16 | 13G | Zenas BioPharma, Inc. ZBIO |
Xencor Inc XNCR |
3,098,380 7.400% |
3,098,380 (New Position) |
Filing History |
| 2024-09-25 6:00 pm Purchase |
2024-09-16 | 13G | Zenas BioPharma, Inc. ZBIO |
NEA 18 Venture Growth Equity L.P. | 2,613,948 6.600% |
2,613,948 (New Position) |
Filing History |
| 2024-09-23 8:56 pm Purchase |
2024-09-16 | 13D | Zenas BioPharma, Inc. ZBIO |
SR ONE CAPITAL MANAGEMENT LLC | 4,911,539 12.300% |
4,911,539 (New Position) |
Filing History |
| 2024-09-23 8:11 pm Purchase |
2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX |
Longitude Capital Partners IV LLC | 2,501,934 6.000% |
2,501,934 (New Position) |
Filing History |
| 2024-09-23 4:16 pm Purchase |
2024-09-16 | 13D | Bicara Therapeutics Inc. Common Stock BCAX |
Enavate Sciences GP, LLC | 3,761,359 9.000% |
3,761,359 (New Position) |
Filing History |